Skip to main content
Premium Trial:

Request an Annual Quote

Caleb Brett to Buy PerkinElmer s Automotive Research Division

NEW YORK, Nov. 2 (GenomeWeb News) - PerkinElmer agreed on Oct. 26 to sell its automotive division as part of  its divesture of non-life science businesses, the company said in a filing with the Securities and Exchange Commission yesterday.


As GenomeWeb News reported last month, PerkinElmer will sell its aerospace, semiconductor, and fluid-testing businesses in order to shift its focus to the health sciences and photonic markets.


PerkinElmer agreed to sell to Caleb Brett USA all of its assets related to developing, marketing and providing fuel, lubricant, and other vehicle-based testing services for the gasoline engine and petrochemical industries, the SEC filing said.


Caleb Brett will pay $34.5 million in cash, subject to a post-closing adjustment based on PerkinElmer's working capital at closing.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.